Involuntary movements caused by tardive dyskinesia (TD), a movement disorder induced by dopamine-receptor antagonists like ...
This football season, Teva is increasing education around tardive dyskinesia (TD) by launching ‘The Other TD’ campaign TD is a chronic movement ...
Uncontrollable movements from tardive dyskinesia (TD) can put a strain on your daily life, physically and mentally. Developing a stress management routine, employing social strategies, and seeking ...
In 2024, several research and pharmacological advancements were made for tardive dyskinesia, a movement disorder caused by dopamine-blocking medications. Below are some of the highlights of the year.
Tracking your tardive dyskinesia symptoms provides insight into what’s going on. Tardive dyskinesia (TD) is a movement disorder that causes certain uncontrollable movements in different parts of the ...
Learn about tardive dyskinesia symptoms, causes, diagnosis, treatment options, and chances of remission with expert guidance and timely intervention.
It started my second year of college. I lost a good friend to suicide, and it just sent me into, like, the deepest depression. I started seeing the psychiatrist, and he put me on the antipsychotics.
The findings of this study align with prior research that suggests lower effective doses of clozapine are required for patients of Indian descent compared to Western populations. Switching patients of ...
TipRanks on MSN
Teva launches ‘The Other TD’ disease education campaign
Pharmaceuticals announced the launch of ‘The Other TD,’ a disease education campaign leveraging the broad recognition of football ...
Tardive dyskinesia is a common side effect caused by antipsychotic use. It is a neurological disorder characterized by involuntary, repetitive movements, often involving the face, mouth, tongue, and ...
Currently there are two FDA approved treatment options for tardive dyskinesia. There are two medications that are VMAT2 inhibitors. These are valbenazine (Ingrezza) and deutetrabenazine (Austedo) made ...
The KINECT-PRO™ analysis is the first and only of its kind to report both remission of tardive dyskinesia symptoms and associated improvements in patient-reported outcomes. Post-hoc analysis from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results